SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-143243
Filing Date
2018-04-30
Accepted
2018-04-30 16:24:55
Documents
7
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d528920ddefa14a.htm DEFA14A 35761
2 GRAPHIC g528920g05e15.jpg GRAPHIC 23408
3 GRAPHIC g528920g16q56.jpg GRAPHIC 13701
4 GRAPHIC g528920g50i50.jpg GRAPHIC 16914
5 GRAPHIC g528920g62d05.jpg GRAPHIC 24728
6 GRAPHIC g528920g76c99.jpg GRAPHIC 32714
7 GRAPHIC g528920g87n84.jpg GRAPHIC 13084
  Complete submission text file 0001193125-18-143243.txt   208929
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36296 | Film No.: 18790160
SIC: 2834 Pharmaceutical Preparations